Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

284results about How to "Prevent agglutination" patented technology

Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof

The invention relates to a traditional Chinese medicine for treating cardiac, cerebral and vascular diseases; the drug is composed of forty kinds of crude drugs by weight parts: milk veteh, salvia miltiorrhiza, root of common peony, ligusticum wallichii, lumbricus, sanguisuga, rhizoma acori graminei, polygala root, red ocher, oyster, angelica, the root of kudzu vine, arisaema cum bile and the like; the preparation method is that: (1) the crude drugs are prepared into water extract liquid; (2) the water extract liquid is prepared into oral liquid; (3)the water extract liquid obtained by the step (1) is dried, crushed, sieved, undersize material is extracted powder; (4) the extracted powder prepared by the step (3) is prepared into various dosage forms. The preparation method of crude powder is that: lime earth of the crude drugs is sieved, and then the crude drugs are crushed and sieved, the undersize material is taken out and is sterilized to be crude powder, and the crude powder is prepared into various dosage forms. The traditional Chinese medicine has the major functions of treating miocardial infarction and angina caused by coronary heart disease, high blood pressure and cerebral thrombosis, hemiplegia, cerebral infarction, cerebrovascular accident, sequel of apoplexy and other symptoms, and the medicine has obvious effect on headache, dizziness and heart cerebrovascular diseases caused by high blood pressure and cerebral circulation insufficiency.
Owner:卢速江

Chinese medicinal composition for resisting cardiovascular and cerebrovascular diseases

The invention discloses a Chinese medicine combination for treating cardio-cerebral vascular diseases, which is composed of raw materials with the following parts by weight: 30-50 parts of radix astragali, 20-25 parts of angelica, 15-20 parts of hemlock parsley, 30-50 parts of salvia miltiorrhiza, 15-20 parts of pseudo-ginseng, 15-20 parts of hawkthorn and 20-30 parts of radix puerariae; the Chinese medicine combination of the invention has ingenious compatibility, simple prescription, broad source of raw materials, low price as well as the efficacies of tonifying both qi and blood, balancing yin and yang, activating blood circulation and dissolving stasis; the Chinese medicine combination can soften blood vessels through reducing blood fat and blood viscosity and eliminating blood scales and finally achieve the purposes of smoothing blood circulation and activating cardio-cerebral function; furthermore, the Chinese medicine combination has unique efficacy for resisting atherosclerosis as well as significant curative effect on cardio-cerebral vascular diseases like coronary heart disease, cerebral thrombosis, and the like; the total clinical effective rate can reach over 95% and the Chinese medicine combination can achieve good preventive and health care effect through long-term oral administration and has safe oral administration and no toxicity and side effect.
Owner:谭镒昌

Medicine for treating cardiovascular and cerebrovascular diseases

The invention relates to a medicine for treating cardiovascular and cerebrovascular diseases, and belongs to the technical field of traditional Chinese medicines. The invention aims at providing the medicine for treating the cardiovascular and cerebrovascular diseases, which has small side effect and obvious therapeutic effect. The invention discloses the medicine for treating the cardiovascular and cerebrovascular diseases, which is characterized in that: the medicine is prepared from the following pharmaceutical raw materials in parts by weight: 800 parts of ginkgo leaves, 500 parts of radix paeoniae alba, 500 parts of liquorice, 500 parts of witloof, 200 parts of radix notoginseng, 100 parts of lychee seeds and 100 parts of lumbricus. The medicine has the following beneficial effects: a pharmaceutical composition in the invention has small side effect and obvious therapeutic effect; when the medicine is adopted, the experimental carotid artery thrombosis time of a rat can be obviously prolonged, and the platelet aggregation of the rat can be obviously inhibited; and the medicine has the obvious therapeutic effects of resisting thrombosis, and treating thrombotic diseases, ischemic cardiovascular and cerebrovascular diseases, blood circulation obstacles and the like.
Owner:南通市通州区平潮镇新坝卫生院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products